Director, Computational Pathology Biomarker Lead (Oncology/BioPharma) (m/f/d)
Do you thrive at the intersection of AI innovation and clinical translation? Do you have expertise in, and a passion for leading cross functional teams to drive innovation? Would you like to apply your expertise to impact the Oncology and/or BioPharma strategic vision in a company that follows the science and turns ideas into life changing medicines? Then AstraZeneca might be the one for you! In this position you will work with a multi-disciplinary team to pioneer AI-enabled computational pathology and multi-modal biomarkers that fundamentally change how we approach patient selection and drug development, aiming to improve clinical outcomes. You will have the opportunity to impact an industry-leading portfolio of targeted therapy programs from inception through to life cycle management for marketed drugs. This role is based at our Munch, Germany office.
ABOUT ASTRAZENECA
AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines for some of the world’s most serious diseases. But we’re more than one of the world’s leading pharmaceutical companies.
SITE DESCRIPTION - Munich, Germany
At Computational Pathology Munich (CPM), we make a significant contribution to high-performance, data-driven research and development. Our team operates in a demanding, fast-paced environment where excellent collaboration, clear communication and precise organization are critical.
BUSINESS AREA AstraZeneca's Enterprise AI organization is building the future of drug development, a fully integrated AI engine that connects data, technology, and expertise to accelerate breakthroughs across our portfolio. Within AI for Computational Pathology and Biomarkers, we're pioneering AI-powered solutions that transform patient selection, biomarker development, and clinical decision-making at enterprise scale. We thrive on collaboration: actively leveraging capabilities across the organization, promoting reuse, and scaling innovations from concept to global impact. Our measure of success isn't just innovation—it's adoption, scale, and tangible results across therapeutic areas and geographies.
Key Responsibilities
Provide strategic scientific leadership for AI-powered computational pathology and multimodal biomarker development across AstraZeneca's Oncology and/or BioPharmaceuticals portfolio, delivering robust biomarkers that enable patient selection from target validation through life cycle management. Lead cross-functional matrix teams to implement strategic vision with end-to-end ownership toward clinical implementation. Operating at the convergence of data, AI innovation, and tumor biology, develop reusable biomarker platforms that may travel with biological mechanisms across cancer types and treatment modalities. Deliver high-impact translational insights that inform critical drug development decisions, shape portfolio strategy, and enable regulatory submissions and clinical operationalization in.
Experience and Capabilities
Essential
Desirable
What you can expect:
Date Posted
19-Mai-2026
Closing Date
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.